Phreesia, Inc. (LON:0A23)
London
· Delayed Price · Currency is GBP · Price in USD 28.50
-0.54 (-1.86%)
At close: Jan 31, 2025
Phreesia Revenue
In the fiscal year ending January 31, 2025, Phreesia had annual revenue of $419.81M USD with 17.83% growth. Phreesia had revenue of $109.68M in the quarter ending January 31, 2025, with 15.45% growth.
Revenue
$419.81M
Revenue Growth
+17.83%
P/S Ratio
3.17
Revenue / Employee
$201.64K
Employees
2,082
Market Cap
1.07B GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Phreesia News
- 5 weeks ago - Phreesia Maintains Its Momentum - Seeking Alpha
- 6 weeks ago - Phreesia Named to G2's List of 2025 Best Healthcare Software Products - Business Wire
- 6 weeks ago - Phreesia up 7% following strong Q4 results - Seeking Alpha
- 6 weeks ago - Q4 2025 Phreesia Inc Earnings Call Transcript - GuruFocus
- 6 weeks ago - Phreesia, Inc. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 weeks ago - Phreesia, Inc. (PHR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Phreesia GAAP EPS of -$0.11 beats by $0.07, revenue of $109.68M beats by $0.75M - Seeking Alpha
- 6 weeks ago - Phreesia Announces Fourth Quarter Fiscal 2025 Results - Business Wire